Marktumfang und wichtige Erkenntnisse für Rinderperikardklappen 2021-2031
Bovine Pericardial Valve Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 2.60 Billion |
| Market Size by 2031 | US$ 6.08 Billion |
| Global CAGR (2023 - 2031) | 9.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered | By Valve Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
Bovine Pericardial Valve Market Players Density: Understanding Its Impact on Business Dynamics
The Bovine Pericardial Valve Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Bovine Pericardial Valve Market are:
- Edwards Lifesciences
- Medtronic
- Boston Scientific
- Labor Laboratories
- Meril Life Sciences
- Abbott
Disclaimer
: The companies listed above are not ranked in any particular order.
- Get the Bovine Pericardial Valve Market top key players overview
Bovine Pericardial Valve Market News and Recent Developments
The Bovine Pericardial Valve Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for bovine pericardial valves:
- Medtronic launched the Avalus Ultra valve, designed to facilitate ease of use at implant and lifetime patient management. The product is a next-generation surgical aortic tissue valve that features a polyetheretherketone (PEEK) base frame for consistent circularity, an industry-leading Effective Orifice Area (EOA) that allows for greater blood flow and a radiopaque coil for clear visibility for future valve-in-valve procedures (Source: Medtronic, Press Release, 2024)
- Edwards Lifesciences Corporation launched the SAPIEN 3 Ultra RESILIA valve, which incorporates the company's RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve. RESILIA tissue is a bovine pericardial tissue treated with advanced anti-calcification technology. It serves as the platform for new valves, including the next-generation SAPIEN X4 valve undergoing clinical trials. (Source: Edwards Lifesciences, Company Website, 2022)
Bovine Pericardial Valve Market Report Coverage and Deliverables
The “Bovine Pericardial Valve Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Get Free Sample For